Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 8. Click on ID to see further detail.
IDOV_4971Virus nameVaccinia virusVirus strainwild typeVirus genome typeDNAVirus familyPoxviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineShanghai cell collectionOrigin of cell lineLewis lung cancer cell lineCell lineLLCConcentration of cell lineNAIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration2 MOIIn-vitro result60% cell viability after 24 hoursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedInduction of apoptosisImmunogenic effectNAClinical trialNAPMID27208781
IDOV_4972Virus nameVaccinia virusVirus strainwild typeVirus genome typeDNAVirus familyPoxviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineShanghai cell collectionOrigin of cell lineLewis lung cancer cell lineCell lineLLCConcentration of cell lineNAIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration5 MOIIn-vitro result40% cell viability after 24 hoursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedInduction of apoptosisImmunogenic effectNAClinical trialNAPMID27208781
IDOV_4973Virus nameVaccinia virusVirus strainwild typeVirus genome typeDNAVirus familyPoxviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineShanghai cell collectionOrigin of cell lineLewis lung cancer cell lineCell lineLLCConcentration of cell lineNAIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration2 MOIIn-vitro result20% cell viability after 48 hoursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedInduction of apoptosisImmunogenic effectNAClinical trialNAPMID27208781
IDOV_4974Virus nameVaccinia virusVirus strainwild typeVirus genome typeDNAVirus familyPoxviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineShanghai cell collectionOrigin of cell lineLewis lung cancer cell lineCell lineLLCConcentration of cell lineNAIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration5 MOIIn-vitro result5% cell viability after 48 hoursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedInduction of apoptosisImmunogenic effectNAClinical trialNAPMID27208781
IDOV_4975Virus nameVaccinia virusVirus strainvv-IL-24Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationInsertion of IL-24 gene in tk locusVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeVirus expressing IL-24 geneSource of cell lineShanghai cell collectionOrigin of cell lineLewis lung cancer cell lineCell lineLLCConcentration of cell lineNAIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration2 MOIIn-vitro result44% cell viability after 24 hoursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedInduction of apoptosisImmunogenic effectNAClinical trialNAPMID27208781
IDOV_4976Virus nameVaccinia virusVirus strainvv-IL-24Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationInsertion of IL-24 gene in tk locusVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeVirus expressing IL-24 geneSource of cell lineShanghai cell collectionOrigin of cell lineLewis lung cancer cell lineCell lineLLCConcentration of cell lineNAIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration5 MOIIn-vitro result35% cell viability after 24 hoursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedInduction of apoptosisImmunogenic effectNAClinical trialNAPMID27208781
IDOV_4977Virus nameVaccinia virusVirus strainvv-IL-24Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationInsertion of IL-24 gene in tk locusVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeVirus expressing IL-24 geneSource of cell lineShanghai cell collectionOrigin of cell lineLewis lung cancer cell lineCell lineLLCConcentration of cell lineNAIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration2 MOIIn-vitro result20% cell viability after 48 hoursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedInduction of apoptosisImmunogenic effectNAClinical trialNAPMID27208781
IDOV_4978Virus nameVaccinia virusVirus strainvv-IL-24Virus genome typeDNAVirus familyPoxviridaeVirus genome modificationInsertion of IL-24 gene in tk locusVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeVirus expressing IL-24 geneSource of cell lineShanghai cell collectionOrigin of cell lineLewis lung cancer cell lineCell lineLLCConcentration of cell lineNAIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration5 MOIIn-vitro result2% cell viability after 48 hoursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedInduction of apoptosisImmunogenic effectNAClinical trialNAPMID27208781